Blue Bell, PA – IPS proudly welcomes April Chen, AIA, LEED AP, Paul Szafir, AIA, LEED AP, and Nevine William, AIA, LEED AP, to its Global Strategy & Technology (GS&T) Group. These strategic hires reinforce IPS’ commitment to providing clients with expert guidance in designing advanced facilities that balance technical excellence with operational, regulatory, and business success. All three hires bring extensive experience in designing and managing facilities that produce cutting-edge therapies such as mRNA vaccines, CAR-T cell therapies, and gene editing technologies.
The GS&T Group is more than a team of subject matter experts; it's a consulting powerhouse uniquely positioned to translate technical expertise into actionable business strategies. By integrating best practices in process design, facility planning, and operational efficiency, GS&T helps clients make sound decisions that optimize their technical operations and align with long-term business goals. Collectively, all three experts have worked on significant international projects, including facilities in Japan, Qatar, and Germany, showcasing their ability to support IPS' client base globally.
“Our GS&T Group exists to maintain our position as knowledge leaders of choice in the pharmaceutical and biopharmaceutical industries,” said Jason Collins, Director of Process Architecture at IPS. “April, Paul, and Nevine bring decades of experience designing innovative facilities and a deep understanding of how to create operational and business value. Their expertise strengthens our ability to guide clients in building sustainable, future-ready facilities for the next generation of therapies.”
About the New Hires:
April Chen, AIA, LEED AP: April has extensive experience leading pharmaceutical projects from concept to construction. Her expertise in lab planning, hazardous materials handling, and sustainable design ensures that client facilities meet both technical and operational goals.
Paul Szafir, AIA, LEED AP: Paul is a recognized leader in process architecture, contributing to award-winning projects that set benchmarks in operational efficiency and innovation. His expertise spans CGMP facility design for gene and cell therapy and sustainable construction practices.
Nevine William, AIA, LEED AP: Nevine specializes in designing multi-product facilities for advanced therapeutics, including mRNA vaccines and viral vectors. Her work ensures seamless integration of technical processes with operational workflows, enabling clients to scale effectively.
As life sciences industries evolve, IPS remains committed to helping its clients adapt, innovate, and thrive by providing unmatched expertise and strategic consulting.
